These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21925445)

  • 41. Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.
    Reynolds K; Viswanathan HN; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE; O'Malley CD
    Qual Life Res; 2014 Sep; 23(7):2109-20. PubMed ID: 24604077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design of the POSSIBLE UStrade mark Study: postmenopausal women's compliance and persistence with osteoporosis medications.
    Barrett-Connor E; Ensrud K; Tosteson AN; Varon SF; Anthony M; Daizadeh N; Wade S
    Osteoporos Int; 2009 Mar; 20(3):463-72. PubMed ID: 18607669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adherence to bisphosphonates in the general population: a study in patients referred to a primary care service.
    Donato P; Pepe J; Colangelo L; Danese V; Cecchetti V; Minisola S; Cipriani C
    Arch Osteoporos; 2019 Mar; 14(1):42. PubMed ID: 30900048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment.
    Huas D; Debiais F; Blotman F; Cortet B; Mercier F; Rousseaux C; Berger V; Gaudin AF; Cotté FE
    BMC Womens Health; 2010 Aug; 10():26. PubMed ID: 20727140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea.
    Byun DW; Moon SH; Kim T; Lee HH; Park HM; Kang MI; Ha YC; Chung HY; Yoon BK; Kim TY; Chae SU; Shin CS; Yang KH; Lee JH; Chang JS; Kim SH; Kim IJ; Koh JM; Jung JH; Yi KW; Yoo JJ; Chung DJ; Lee YK; Yoon HK; Hong S; Kim DY; Baek KH; Kim HJ; Kim YJ; Kang S; Min YK
    J Bone Miner Metab; 2019 May; 37(3):563-572. PubMed ID: 30238428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis.
    Yang HY; Huang JH; Chiu HW; Lin YK; Hsu CY; Chen YJ
    Medicine (Baltimore); 2018 Oct; 97(43):e12947. PubMed ID: 30412111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-related problems in patients with osteoporosis.
    Ilić D; Bukumirić Z; Janković S
    Vojnosanit Pregl; 2016 Mar; 73(3):261-5. PubMed ID: 27295911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study.
    Guilera M; Fuentes M; Grifols M; Ferrer J; Badia X;
    Osteoporos Int; 2006; 17(5):664-71. PubMed ID: 16437191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between osteoporosis treatment and severe periodontitis in postmenopausal women.
    Passos-Soares JS; Vianna MIP; Gomes-Filho IS; Cruz SS; Barreto ML; Adan LF; Rösing CK; Trindade SC; Cerqueira EMM; Scannapieco FA
    Menopause; 2017 Jul; 24(7):789-795. PubMed ID: 28225430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medication persistence in older women with osteoporosis: a pilot study.
    Gillette C; Howerton DM; Williams BD; Mahmood MA
    Osteoporos Int; 2015 Dec; 26(12):2883-8. PubMed ID: 26194492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Self-reported adherence to prescribed medicines during pregnancy].
    Oliveira Filho AD; Gama DP; Leopardi Md; Dias JM; Lyra Júnior DP; Neves SJ
    Rev Bras Ginecol Obstet; 2012 Apr; 34(4):147-52. PubMed ID: 22584809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The lack of adherence to antiosteoporotic drugs: crossing methods, the key to adherence measurement?].
    Saliba L; Boisson L; Sallerin B; Laroche M; Despas F
    Therapie; 2014; 69(5):383-9. PubMed ID: 25269139
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmaceutical intervention on the therapeutic adherence in patients with chronic renal disease].
    Sánchez-Gili M; Toro-Chico P; Pérez-Encinas M; Gómez-Pedrero AM; Portolés-Pérez JM
    Rev Calid Asist; 2011; 26(3):146-51. PubMed ID: 21435928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women.
    Breuil V; Cortet B; Cotté FE; Arnould B; Dias-Barbosa C; Gaudin AF; Regnault A; Roborel de Climens A; Legrand E
    Osteoporos Int; 2012 Feb; 23(2):445-55. PubMed ID: 21625889
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A study on the subjective compliance and acceptance of oral lanzoprazole in traumatology. The ECOFT-TR Study].
    Márquez-Contreras E; Gil-Guillén V; Nadal-Sánchez A; Plazas-Fernández MJ; Heras-Navarro J; Galván-Cervera J; Porcel-Carbonell J
    Reumatol Clin; 2009; 5(2):49-54. PubMed ID: 21794577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Adherence in patients with chronic treatment: data of "adherence day 2013"].
    Ibarra Barrueta O; Morillo Verdugo R; Rudi Sola N; Ventura Cerdá JM; Navarro Aznárez H
    Farm Hosp; 2015 Mar; 39(2):109-13. PubMed ID: 25817090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.
    Lau E; Papaioannou A; Dolovich L; Adachi J; Sawka AM; Burns S; Nair K; Pathak A
    Can Fam Physician; 2008 Mar; 54(3):394-402. PubMed ID: 18337534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs.
    Chan SP; Scott BB; Sen SS
    BMC Musculoskelet Disord; 2010 Oct; 11():248. PubMed ID: 20977729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The invisible disease: making sense of an osteoporosis diagnosis in older age.
    Weston JM; Norris EV; Clark EM
    Qual Health Res; 2011 Dec; 21(12):1692-704. PubMed ID: 21810994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Patient compliance with drug therapy in temporal arteritis].
    Le Gal V; Queyrel V; Michon-Pasturel U; Fauchais AL; Lambert M; Hachulla E; Hatron PY; Devulder B
    Rev Med Interne; 2003 Dec; 24(12):775-80. PubMed ID: 14656636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.